Rapport Therapeutics, Inc. Common Stock
RAPP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$27 | -$27 | -$24 | -$20 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $4 | $4 | $3 |
| Change in WC | $4 | -$3 | -$0 | $1 |
| Other Non-Cash | $6 | $0 | -$0 | $1 |
| Operating Cash Flow | -$17 | -$25 | -$20 | -$14 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$102 | -$13 | -$44 | -$85 |
| Inv. Sales/Matur. | $45 | $35 | $65 | $117 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$57 | $23 | $21 | $32 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $271 | -$0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | -$0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $271 | -$0 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $196 | -$3 | $1 | $17 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $55 | $58 | $57 | $39 |
| End Cash | $251 | $55 | $58 | $57 |
| Free Cash Flow | -$18 | -$25 | -$21 | -$15 |